Drug Profile
Research programme: cardiovascular diagnostic imaging - EPIX Pharmaceuticals
Alternative Names: EP-3533; EP-3600Latest Information Update: 06 May 2010
Price :
$50
*
At a glance
- Originator EPIX Pharmaceuticals
- Class
- Mechanism of Action Image enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 05 May 2010 Intellectual properties pertaining to EP 3600 are being auctioned in the US (http://www.finnwarnkegayton.com)
- 06 Feb 2007 Preclinical trials in Magnetic resonance imaging in USA (unspecified route)